Circassia Pharmaceuticals (LON:CIR)

Circassia Pharmaceuticals (LON:CIR)


Share Price
19.84 p
Change
-0.659 (-3.21 %)
Market Cap
£74.43 m
Proactive Investors - Run By Investors For Investors

Circassia Pharmaceuticals

Circassia is a specialty pharmaceutical company focused on respiratory disease. Our growing commercial organization promotes our innovative asthma management products directly to specialist physicians in a number of key markets, and we market the chronic obstructive pulmonary disease (COPD) product Tudorza® in the United States. We are expanding our commercial platform in China, and are...

EPIC: CIR
Market: LSE:CIR
52-week High/Low: 82.70p / 13.25p
Sector: Pharma & Biotech
Market Cap: £74.43 m
Website: www.circassia.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Circassia Pharmaceuticals


© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use